z-logo
Premium
Clinical practice patterns in the assessment and management of low testosterone in men: an international survey of endocrinologists
Author(s) -
Grossmann Mathis,
Anawalt Bradley D.,
Wu Frederick C.W.
Publication year - 2015
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.12594
Subject(s) - testosterone (patch) , medicine , androgen deficiency , overweight , androgen , endocrinology , clinical practice , endocrine system , demography , gynecology , body mass index , family medicine , hormone , sociology
Summary Objective To document current practices in the approach to low testosterone in older men. Given that recommendations are based on low‐level evidence, we hypothesized that there would be a wide variability in clinical practice patterns. Design Members of all major endocrine and andrological societies were invited to participate in a Web‐based survey of the diagnostic work‐up and management of a hypothetical index case of a 61‐year old overweight man presenting with symptoms suggestive of androgen deficiency, without evidence of hypothalamic‐pituitary‐gonadal ( HPT ) axis disease. Results Nine hundred and forty‐three respondents (91·2% adult endocrinologists) from Northern America (63·7%), Europe (12·7%), Oceania (8·2%), Latin America and Caribbean (7·6%), and the Middle East, Asia, or Africa (7·8%) completed the survey. Response rates among participating societies ranged from 4·1–20·0%. There was a wide variability in clinical practice patterns, especially regarding biochemical diagnosis of androgen deficiency, exclusion of HPT axis pathology, and monitoring for prostate cancer. In a man with suggestive symptoms, 42·4% of participants would offer testosterone treatment below a serum total testosterone of 10·4 nmol/l (300 ng/dl). A total of 46·0% of participants were, over the last five years, ‘less inclined’ to prescribe testosterone to men with nonspecific symptoms and borderline testosterone levels, compared to ‘no change’ (29·3%) or ‘more inclined’ (24·7%), P  < 0·001. Conclusions This large‐scale international survey shows a wide variability in the management of lowered testosterone in older men, with deviations from current clinical practice guidelines, and a temporal trend towards increasing reluctance to prescribe testosterone to men without classical hypogonadism. These findings highlight the need for better evidence to guide clinicians regarding testosterone therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here